JNJ Ex-Dividend Date & Dividend Calculator

Johnson & Johnson (JNJ) is a dividend-growth name with a track record of steady dividend increases, currently paying a quarterly distribution at a yield of 1.9%. The annual growth rate of the dividend matters more than the absolute yield for long-run compounding. Combined with a dividend-reinvestment (DRIP) strategy, long-term portfolio income can grow substantially.

For dividend-growth names, a track record of maintaining or raising the dividend even through recessions is a key selection criterion. Check dividend continuity and payout ratio together. See the complete dividend-types guide and the full dividend-dates guide.

Selection criteria — JNJ, a healthcare company spanning pharmaceuticals and medical devices, sits in the dividend-growth category. It's an individual company with a long history of maintaining and raising its dividend.

Payout mechanics — JNJ pays quarterly at 1.9% (as of 2026.09.06). The headline number is modest by design; what matters more here is that payments has stayed very stable payment to payment (variability score 0.03). The per-payment amount is about $1.3400, paid roughly 4 times a year. This figure is recalculated every period, so it isn't guaranteed to hold going forward — it's a reference point based on past payment history. When making decisions about JNJ, it's safer to treat the $1.3400 figure above as one reference among several rather than the sole basis.

Risk to watch — Don't read the modest headline yield as undervaluation — in this category, the rate of increase matters more than the yield itself. This isn't an estimate — 2026-08-25 is the confirmed next ex-dividend date, and you need to hold through the prior close to qualify. See DRIP reinvestment strategy and dividend-growth investing basics, then check the 5-year simulator for the compounding effect. When evaluating JNJ, cross-check the $1.3400 per-payment figure against the other numbers in the card above — no single metric should carry the whole judgment.

Summary — JNJ (Johnson & Johnson) pays $1.3400 per period on a quarterly cadence. Simply annualized at 4x/year, that's about $5.36 — purely arithmetic assuming current terms hold, nothing more. None of this is static — JNJ's payments has stayed very stable payment to payment (variability score 0.03), and the schedule above reflects the most recently known ex-dividend timing rather than a fixed calendar. Re-check before relying on any single figure here. When evaluating JNJ, cross-check the $1.3400 per-payment figure against the other numbers in the card above — no single metric should carry the whole judgment.